Cangrelor in a challenging scenario of concomitant ischaemic stroke, pulmonary embolism, and ST-elevation myocardial infarction: a case report.
Federico OliveriLorenzo TuaRita CamporotondoValeria GrittiSergio LeonardiPublished in: European heart journal. Case reports (2024)
Prolonged cangrelor bridging at a reduced dose of 0.75 μg/kg/min may represent an effective and safe option in acute patients requiring P2Y12 inhibition and presenting both high ischaemic and high bleeding risks.
Keyphrases
- pulmonary embolism
- st elevation myocardial infarction
- end stage renal disease
- percutaneous coronary intervention
- inferior vena cava
- ejection fraction
- newly diagnosed
- liver failure
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- case report
- patient reported outcomes
- risk assessment
- respiratory failure
- intensive care unit